INTELLIGENT BIO SOLUTIONS INC. 8-K

What Happened
Intelligent Bio Solutions Inc. announced it has regained compliance with Nasdaq Listing Rule 5550(a)(2) after receiving a letter on January 7, 2026 confirming the company's closing bid price was $1.00 or greater for 14 consecutive business days (December 16, 2025 to January 6, 2026). The company had previously disclosed a deficiency notice dated December 16, 2025 that its closing bid price had been below $1.00 for 30 consecutive business days.

Key Details

• Nasdaq deficiency (Bid Price Notice) initially received and reported on December 16, 2025 due to sub-$1.00 closing bid for 30 consecutive business days.
• On January 7, 2026 Nasdaq notified the company it met the $1.00 minimum bid price requirement for 14 consecutive business days (Dec 16, 2025–Jan 6, 2026).
• Listing rule referenced: Nasdaq Listing Rule 5550(a)(2) (the $1.00 minimum bid-price requirement).
• Nasdaq staff indicated the company is now in compliance and the matter is closed.

Why It Matters
Regaining compliance means Intelligent Bio Solutions remains listed on the Nasdaq Capital Market for now, avoiding the immediate risk of delisting tied to this specific bid-price deficiency. For investors, this preserves current trading venue, liquidity, and visibility associated with a Nasdaq listing; however, continued compliance depends on the company's future closing bid prices. Monitor share-price trends and future filings for any further Nasdaq notifications.